Perrigo
Headquartered in Ireland, Perrigo Company plc is a global healthcare supplier that develops, manufactures and distributes over-the-counter (OTC) and generic prescription (Rx) pharmaceuticals, infant formulas, nutritional products, animal health, dietary supplements, active pharmaceutical ingredients (API), and medical diagnostic products and receives royalties from Multiple Sclerosis drug Tysabri.
In 2013 it acquired Irish pharma company Elan.
Financial Data
-
31st Dec 17 Source: CRO
- €4.1 billion turnover
-
€229.2 million
profit - 10,400 employees
-
30th Jun 16 Source: CRO
- €5 billion turnover
- 13,300 employees
- 3 more years available »
Ranking
By Turnover
(€4.1 billion)- 24th in Top Companies
- 6th in Health
- 5th in Pharma
By Employees
(10,400)- 20th in Top Companies
- 4th in Health
- 4th in Pharma
-
- 10,400
- €4.1 billion
Employees
- Uwe Röhrhoff CEO/Managing Director
Latest News
- 7:34am Providence Resources reduces losses after amending Barryroe deal
- 6:30am Stock exchange CEO’s €5.75m pay day, Ryanair turbulence, and more warnings of a slowdown
- 5:55am Irish tech firms see VC funding fall for first time since 2011
- 5:55am Adobe’s Irish subsidiary to pay $3.2bn dividend to its parent
- 5:33am New online property crowdfunding platform goes live